Market revenue in 2023 | USD 770.8 million |
Market revenue in 2030 | USD 1,272.5 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.44% in 2023. Horizon Databook has segmented the South Korea in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is known for its advanced medical technology and infrastructure, which includes advanced fertility clinics equipped with modern facilities and skilled medical professionals. These clinics offer a wide range of fertility treatments, including IVF, to address various infertility issues.
The price can vary depending on factors such as the condition of the woman and her partner, the specific protocol recommended by the fertility clinic, and the inclusion of optional tests like Preimplantation Genetic Diagnosis (PGD) Or Preimplantation Genetic Screening (PGS).
South Korea currently has the lowest birth rate per woman in the world. The fertility rate, which represents the average number of children born to a woman over her reproductive lifespan, was recorded at only 0.81 in the country in 2021.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into South Korea in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account